Fred A. Middleton - May 19, 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role
Director, 10%+ Owner
Signature
By John Dunn, Attorney-in-Fact
Stock symbol
CALC
Transactions as of
May 19, 2023
Transactions value $
$28,500
Form type
4
Date filed
5/22/2023, 03:23 PM
Previous filing
Jun 28, 2023
Next filing
Jun 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALC Common Stock Purchase $28.5K +10K $2.85 10K May 19, 2023 Direct
holding CALC Common Stock 703K May 19, 2023 By Sanderling Venture Partners VI, L.P. F1
holding CALC Common Stock 583K May 19, 2023 By Sanderling Venture Partners VI Co-Investment Fund, L.P. F1
holding CALC Common Stock 17.7K May 19, 2023 By Sanderling Ventures Management VI F1
holding CALC Common Stock 7.46K May 19, 2023 By Sanderling VI Beteligungs GmbH & Co KG F1
holding CALC Common Stock 8.88K May 19, 2023 By Sanderling VI Limited Partnership F1
holding CALC Common Stock 241K May 19, 2023 By Sanderling Ventures VII, L.P. F2
holding CALC Common Stock 14.4K May 19, 2023 By Sanderling Ventures VII Annex Fund, L.P. F2
holding CALC Common Stock 63.2K May 19, 2023 By Sanderling Ventures VII (Canada), L.P. F2
holding CALC Common Stock 1.55K May 19, 2023 By Sanderling Ventures Management VII F2
holding CALC Common Stock 8.18K May 19, 2023 By Golden Triangle Ventures, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI, LP, Sanderling Venture Partners VI Co-Investment Fund, LP, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (together, the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VI Securities except to the extent of his pecuniary interest therein.
F2 The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP, Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), LP and Sanderling Ventures VII Annex Fund, L.P. (together, the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VII Securities except to the extent of his pecuniary interest therein.
F3 The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.